When you offer phenomenal service, an unrivalled pharma portfolio, and take a global yet personal approach with fantastic partners, it’s only a matter of time before you need to expand.

The countdown has officially started!

We have been quietly working behind the scenes on our new state of the art, ultra-modern lab capable of handling even the most highly potent drugs. We’ve already been GMP inspected by the local state authority, and we’re very nearly ready to welcome our first projects.

Spanning over 500m2, the additional site promises the same level of regulatory rules, standard operating procedures and excellent service as our flagship Prague HQ, and with logistics between the two locations already well established there is no doubt that this expansion will provide the extra capacity needed as Quinta continues to grow.

Excited to hear more about this very special new lab and learn where it’s based? Watch this space!

Also, be sure to follow us on LinkedIn for the latest news and greatest announcements in the pharma industry.

Additional News

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.